Current Status of Onychomycosis Topical Therapy Conducted at Home

Yoshitaka Yoneta, Yoshihiro Imazu, Emiko Uchida, Katsunori Yamaura, Junko Suzuki

Research output: Contribution to journalArticle

Abstract

 Patients usually consult a dermatologist for the treatment of onychomycosis. However, in the case of home care, visiting nurses may assist with bathing, which offers the opportunity to observe patients' feet for possible signs of onychomycosis without causing anxiety. It is estimated that more than 30% of patients receiving home care have onychomycosis. Before the approval of efinaconazole, healthcare personnel hesitated to treat onychomycosis because of: 1) possible side effects, especially liver dysfunction and pain due to repeated blood collection, as a major goal of home care is to minimize pain; and 2) the questionable efficacy of previously available antifungal medications. In addition, many patients report fear of "transmitting athlete's foot to others" and "do not want to show my dirty toenails". On the other hand, caregivers reportedly worry about "athlete's foot being transmitted to them".

Original languageEnglish
Pages (from-to)607-609
Number of pages3
JournalYakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Volume138
Issue number5
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Onychomycosis
Home Care Services
Tinea Pedis
Pain
Community Health Nurses
Therapeutics
Nails
Caregivers
Fear
Liver Diseases
Foot
Anxiety
Delivery of Health Care

Keywords

  • dermatology
  • efinaconazole
  • home care
  • onychomycosis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Current Status of Onychomycosis Topical Therapy Conducted at Home. / Yoneta, Yoshitaka; Imazu, Yoshihiro; Uchida, Emiko; Yamaura, Katsunori; Suzuki, Junko.

In: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, Vol. 138, No. 5, 01.01.2018, p. 607-609.

Research output: Contribution to journalArticle

Yoneta, Yoshitaka ; Imazu, Yoshihiro ; Uchida, Emiko ; Yamaura, Katsunori ; Suzuki, Junko. / Current Status of Onychomycosis Topical Therapy Conducted at Home. In: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2018 ; Vol. 138, No. 5. pp. 607-609.
@article{24045d8afaf3408881b797232d54a598,
title = "Current Status of Onychomycosis Topical Therapy Conducted at Home",
abstract = " Patients usually consult a dermatologist for the treatment of onychomycosis. However, in the case of home care, visiting nurses may assist with bathing, which offers the opportunity to observe patients' feet for possible signs of onychomycosis without causing anxiety. It is estimated that more than 30{\%} of patients receiving home care have onychomycosis. Before the approval of efinaconazole, healthcare personnel hesitated to treat onychomycosis because of: 1) possible side effects, especially liver dysfunction and pain due to repeated blood collection, as a major goal of home care is to minimize pain; and 2) the questionable efficacy of previously available antifungal medications. In addition, many patients report fear of {"}transmitting athlete's foot to others{"} and {"}do not want to show my dirty toenails{"}. On the other hand, caregivers reportedly worry about {"}athlete's foot being transmitted to them{"}.",
keywords = "dermatology, efinaconazole, home care, onychomycosis",
author = "Yoshitaka Yoneta and Yoshihiro Imazu and Emiko Uchida and Katsunori Yamaura and Junko Suzuki",
year = "2018",
month = "1",
day = "1",
doi = "10.1248/yakushi.17-00118-2",
language = "English",
volume = "138",
pages = "607--609",
journal = "Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

TY - JOUR

T1 - Current Status of Onychomycosis Topical Therapy Conducted at Home

AU - Yoneta, Yoshitaka

AU - Imazu, Yoshihiro

AU - Uchida, Emiko

AU - Yamaura, Katsunori

AU - Suzuki, Junko

PY - 2018/1/1

Y1 - 2018/1/1

N2 -  Patients usually consult a dermatologist for the treatment of onychomycosis. However, in the case of home care, visiting nurses may assist with bathing, which offers the opportunity to observe patients' feet for possible signs of onychomycosis without causing anxiety. It is estimated that more than 30% of patients receiving home care have onychomycosis. Before the approval of efinaconazole, healthcare personnel hesitated to treat onychomycosis because of: 1) possible side effects, especially liver dysfunction and pain due to repeated blood collection, as a major goal of home care is to minimize pain; and 2) the questionable efficacy of previously available antifungal medications. In addition, many patients report fear of "transmitting athlete's foot to others" and "do not want to show my dirty toenails". On the other hand, caregivers reportedly worry about "athlete's foot being transmitted to them".

AB -  Patients usually consult a dermatologist for the treatment of onychomycosis. However, in the case of home care, visiting nurses may assist with bathing, which offers the opportunity to observe patients' feet for possible signs of onychomycosis without causing anxiety. It is estimated that more than 30% of patients receiving home care have onychomycosis. Before the approval of efinaconazole, healthcare personnel hesitated to treat onychomycosis because of: 1) possible side effects, especially liver dysfunction and pain due to repeated blood collection, as a major goal of home care is to minimize pain; and 2) the questionable efficacy of previously available antifungal medications. In addition, many patients report fear of "transmitting athlete's foot to others" and "do not want to show my dirty toenails". On the other hand, caregivers reportedly worry about "athlete's foot being transmitted to them".

KW - dermatology

KW - efinaconazole

KW - home care

KW - onychomycosis

UR - http://www.scopus.com/inward/record.url?scp=85050876141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050876141&partnerID=8YFLogxK

U2 - 10.1248/yakushi.17-00118-2

DO - 10.1248/yakushi.17-00118-2

M3 - Article

C2 - 29710001

AN - SCOPUS:85050876141

VL - 138

SP - 607

EP - 609

JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

SN - 0031-6903

IS - 5

ER -